Evidence map›Paper›PMID 38974713›Full record

ReviewMedComm2024

Congenital heart disease: types, pathophysiology, diagnosis, and treatment options.

Xiao Meng, Ming Song, Kai Zhang, Weida Lu, Yunyi Li, Cheng Zhang, Yun Zhang

Abstract readReview
In one paragraph

Review in MedComm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Impacts of COVID-19 on pediatric patients with congenital heart disease: a small systematic and integrative literature review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2025
    Pooled it
  3. Review
  4. Article
  5. The impact of PMScientific reports · 2026
    Article
  6. Review
  7. Intracellular Ionic Remodeling During Fetal Development of Hereditary Cardiomyopathy of the Hamster.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Long-term survival and complications of Fontan patients: where do we stand?American journal of cardiovascular disease · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao MengDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.
Ming SongDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.
Kai ZhangDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.
Weida LuShandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine Qilu Hospital of Shandong University Jinan China.
Yunyi LiDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.
Cheng ZhangDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.
Yun ZhangDepartment of Cardiology State Key Laboratory for Innovation and Transformation of Luobing Theory Qilu Hospital of Shandong University Jinan China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital heart disease (CHD) is a structural abnormality of the heart and/or great vessels and patients with CHD are at an increased risks of various morbidities throughout their lives and reduced long-term survival. Eventually, CHD may result in various complications including heart failure, arrhythmias, stroke, pneumonia, and sudden death. Unfortunately, the exact etiology and pathophysiology of some CHD remain unclear. Although the quality of life and prognosis of patients with CHD have significantly improved following technological advancement, the influence of CHD is lifelong, especially in patients with complicated CHD. Thus, the management of CHD remains a challenge due to its high prevalence. Finally, there are some disagreements on CHD among international guidelines. In this review, we provide an update of the pathophysiology, diagnosis, and treatment in most common type of CHD, including patent foramen ovale, atrial septal defect, ventricular septal defect, atrioventricular septal defect, patent ductus arteriosus, coarctation of the aorta, transposition of the great arteries, congenitally corrected transposition of the great arteries, coronary anomalies, left and right ventricular outflow tract obstruction, tetralogy of Fallot and Ebstein anomaly. In particular, we focus on what is known and what is unknown in these areas, aiming to improve the current understanding of various types of CHD.

Indexed as

congenital heart diseasediagnosisetiologypathophysiologytreatment

Identifiers

PMID38974713
PMCPMC11224996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.